Project

RespiriTB

f32fb9f2-5f11-11eb-917b-acde48001122

Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Export as DATS
Keywords IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials

Contacts